Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2002 3
2003 1
2007 2
2009 2
2010 7
2011 9
2012 2
2013 1
2014 3
2015 3
2016 3
2017 4
2019 5
2020 6
2021 4
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.
Fernández-Espartero MC, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group. Fernández-Espartero MC, et al. Semin Arthritis Rheum. 2011 Feb;40(4):330-7. doi: 10.1016/j.semarthrit.2010.06.004. Epub 2010 Sep 22. Semin Arthritis Rheum. 2011. PMID: 20864146 Review.
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.
Cruz Fernández-Espartero M, Pérez-Zafrilla B, Naranjo A, Esteban C, Ortiz AM, Gómez-Reino JJ, Carmona L; BIOBADASER Study Group. Cruz Fernández-Espartero M, et al. Semin Arthritis Rheum. 2011 Dec;41(3):524-33. doi: 10.1016/j.semarthrit.2011.05.003. Semin Arthritis Rheum. 2011. PMID: 22152489 Review.
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
Rua-Figueroa I, García de Yébenes MJ, Martinez-Barrio J, Galindo Izquierdo M, Calvo Alén J, Fernandez-Nebro A, Menor-Almagro R, Carmona L, Tejera Segura B, Tomero E, Freire-González M, Sangüesa C, Horcada L, Blanco R, Uriarte Itzazelaia E, Narváez J, Rosas Gómez de Salazar JC, Gómez-Sabater S, Morales CM, Andreu JL, Segarra VT, Aurrecoechea E, Perez A, Nóvoa Medina J, Salgado E, Lozano-Rivas N, Montilla C, Ruiz-Lucea E, Arevalo M, Iñiguez C, García-Villanueva MJ, Exposito L, Ibáñez-Barceló M, Bonilla G, Carrión-Barberà I, Erausquin C, Fragio Gil JJ, Pecondón A, Toyos FJ, Cobo T, Muñoz-Jiménez A, Oller J, Nolla JM, Pego-Reigosa JM. Rua-Figueroa I, et al. Among authors: erausquin c. Lupus Sci Med. 2024 Apr 8;11(1):e001096. doi: 10.1136/lupus-2023-001096. Lupus Sci Med. 2024. PMID: 38589223 Free PMC article. Review.
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study.
Álvaro Gracia JM, Sanchez-Piedra C, Manero J, Ruiz-Lucea ME, López-Vives L, Bohorquez C, Martinez-Barrio J, Bonilla G, Vela P, García-Villanueva MJ, Navío-Marco MT, Pavía M, Galindo M, Erausquin C, Gonzalez-Gay MA, Rua-Figueroa I, Pego-Reigosa JM, Castrejon I, Sanchez-Costa JT, González-Dávila E, Diaz-Gonzalez F; COVIDSER study group. Álvaro Gracia JM, et al. Among authors: erausquin c. RMD Open. 2021 Dec;7(3):e001925. doi: 10.1136/rmdopen-2021-001925. RMD Open. 2021. PMID: 34887346 Free PMC article.
Higher Prevalence and Degree of Insulin Resistance in Patients With Rheumatoid Arthritis Than in Patients With Systemic Lupus Erythematosus.
Quevedo-Abeledo JC, Sánchez-Pérez H, Tejera-Segura B, de Armas-Rillo L, Ojeda S, Erausquin C, González-Gay MÁ, Ferraz-Amaro I. Quevedo-Abeledo JC, et al. Among authors: erausquin c. J Rheumatol. 2021 Mar;48(3):339-347. doi: 10.3899/jrheum.200435. Epub 2020 Jun 15. J Rheumatol. 2021. PMID: 32541071 Free article.
Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I, Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez-Taboada V, Olivé A, López-Longo J, Rosas J, Galindo M, Calvo-Alén J, Fernández-Nebro A, Alonso F, Rodríguez-Lozano B, Alberto García Vadillo J, Menor R, Narváez FJ, Erausquin C, García-Aparicio Á, Tomero E, Manrique-Arija S, Horcada L, Uriarte E, Gil S, Blanco R, López-González R, Boteanu A, Freire M, Galisteo C, Rodríguez-Gómez M, Díez-Álvarez E, Pego-Reigosa JM; Sjogrenser and Relesser Researchers and EAS-SER Group. Rúa-Figueroa I, et al. Among authors: erausquin c. Arthritis Care Res (Hoboken). 2017 Jan;69(1):38-45. doi: 10.1002/acr.23015. Epub 2016 Nov 21. Arthritis Care Res (Hoboken). 2017. PMID: 27564390 Free article.
Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain.
Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM; en representación de los investigadores del proyecto RELESSER y del grupo EAS-SER; Investigadores del registro RELESSER en su fase transversal. Rúa-Figueroa Fernández de Larrinoa I, et al. Reumatol Clin (Engl Ed). 2021 May;17(5):245-249. doi: 10.1016/j.reuma.2020.01.006. Epub 2020 Mar 21. Reumatol Clin (Engl Ed). 2021. PMID: 32205082 Free article. English, Spanish.
45 results